Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for separating and preparing trace impurity in etodolac bulk drug

A technology of etodolac and trace impurities, applied in the direction of organic chemistry, can solve the problems of high cost, difficult separation, long separation and purification time, etc., and achieve the effect of high recovery rate

Inactive Publication Date: 2021-06-15
ZHEJIANG CHIRAL MEDICINE CHEM
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Due to the extremely low content of impurity A in etodolac (<0.5%), it is difficult to separate it by traditional separation methods (such as extraction, recrystallization, distillation and traditional column chromatography), while preparative high-performance liquid chromatography is due to Use expensive chromatographic grade reagents and C18 preparative chromatographic columns, high cost and long separation and purification time

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for separating and preparing trace impurity in etodolac bulk drug
  • Method for separating and preparing trace impurity in etodolac bulk drug
  • Method for separating and preparing trace impurity in etodolac bulk drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Embodiment 1, a kind of method that separates and prepares impurity A from etodolac bulk drug, separates impurity A from etodolac bulk drug with countercurrent chromatograph, carries out the following steps successively:

[0047] 1), preparation of two-phase solvent:

[0048] Solvent system ①: the volume ratio of normal hexane: ethyl acetate: ethanol: water = 3:2:3:2 is poured into the liquid separator after preparation to form two kinds of mutually immiscible two-phase solvents, respectively The upper and lower phases of the solvent system ①;

[0049] Solvent system ②: the volume ratio of normal hexane: ethyl acetate: ethanol: water = 2:1:2:1 is poured into the liquid separator after preparation to form two kinds of two-phase solvents that are mutually immiscible, and respectively obtain The upper and lower phases of the solvent system ②;

[0050] 2), 4ml solvent system ① upper phase and 4ml solvent system ① lower phase are mixed, get mixed solvent ①; 500mg etodolac ...

Embodiment 2-1

[0069] Embodiment 2-1, a method for separating and preparing impurity A from etodolac bulk drug:

[0070] Change the injection flow rate of the mobile phase from 5.0ml / min to 6.0ml / min in step 2) of Example 1, and the rest are the same as in Example 1. The finally obtained impurity A has a purity of 96.4% and a recovery rate of 87.7%.

Embodiment 2-2

[0071] Embodiment 2-2, a method for separating and preparing impurity A from etodolac bulk drug:

[0072] Change the injection flow rate of the mobile phase from 5.0ml / min to 4.0ml / min in step 2) of Example 1, and the rest are the same as in Example 1. The final obtained impurity A has a purity of 96.2% and a recovery rate of 85.2%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
recovery rateaaaaaaaaaa
recovery rateaaaaaaaaaa
recovery rateaaaaaaaaaa
Login to View More

Abstract

The invention discloses a method for separating and preparing a trace impurity in an etodolac bulk drug. The molecular formula of the trace impurity is C29H34N2O3, and the trace impurity in the etodolac bulk drug is separated and prepared by adopting a gradient elution high-speed counter-current chromatography. A solvent system of the counter-current chromatography comprises normal hexane, ethyl acetate, ethanol and water. The elution mode is gradient elution. Online monitoring is performed through an ultraviolet detector, target fractions are collected and combined, and rotary evaporation is performed until the fractions are dry to obtain the trace impurity. The method provided by the invention enables the quality of etodolac series products to be easily controlled.

Description

technical field [0001] The invention belongs to the technical field of drug impurity research, and in particular relates to a method for separating and preparing a trace impurity from etodolac crude drug by high-speed countercurrent chromatography. Background technique [0002] Reagents, solvents or catalysts are often added in the pharmaceutical production process. Due to solubility, adsorption, occlusion, co-precipitation, mixed crystal formation and other reasons, it is impossible to completely remove them, resulting in the presence of related impurities in the product. If it is treated with acidic or alkaline reagents, the product may contain acidic or alkaline impurities; after extraction or refining with organic solvents, there may be residual organic solvents in the product. The Chinese Pharmacopoeia stipulates that the residual amount of harmful organic solvents (such as benzene, chloroform, 1,4-dioxane, methylene chloride, pyridine, etc.) introduced in the productio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D491/052
CPCC07D491/052
Inventor 何匡彭家荣朱银龙沈丽洒
Owner ZHEJIANG CHIRAL MEDICINE CHEM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com